Cover 2 Resources
Cover 2 Resources
Ep. 270 - Insys Therapeutic Execs Sentenced: Will Doctors Be Next?
Ep. 270 - Insys Therapeutic Execs Sentenced: Will Doctors Be Next?
Ep. 270 - Insys Therapeutic Execs Sentenced: Will Doctors Be Next?
Friday 24th January 2020
Discover the implications of Insys Therapeutics execs' sentencing on pharma practices and doctors' roles in combating opioid addiction.
31 minutes
Informative
Thought-provoking
Raw
Engaging
Transformative
About this podcast
Overview:
Categories:
Innovative Treatments & Recovery Paths
Family Recovery from Addiction
Sobriety Toolkit
Body & Mind
Navigating Intimate Relationships
Links:
Visit site
Episodes:
284 (View all)
Do you want to link to this podcast?
Get the buttons here!Pharma Execs Sentenced: A Turning Point in the Opioid Crisis?
This is the first time big pharma execs have been convicted and sent to prison for racketeering. It’s arguable whether this sentence achieves justice for the 900-plus lives lost to opioid addiction that began with...
What happens when pharmaceutical executives face the music for their actions? In this compelling episode of Cover 2 Resources, Palm Beach Post reporters Pat Beall and John Pacenti return to discuss the sentencing of former Insys Therapeutics executives. Accused of bribing doctors to prescribe their potent fentanyl spray, Subsys, to patients who didn't need it, these execs now face 1 to 5 ½ years in prison for racketeering.
This case marks a historic moment—it's the first time big pharma execs have been convicted and imprisoned for such charges. But what does this mean for the future of the pharmaceutical industry and, more importantly, for doctors who may be complicit in similar schemes? Beall and Pacenti delve into the broader implications of this landmark case. They explore whether justice was truly served and what this sentencing signals to other pharmaceutical companies. Are doctors next in line for accountability?
The conversation touches on the ethical responsibilities of medical professionals and the need for increased scrutiny and regulation within the industry. Listeners will gain valuable insights into the complexities of the opioid crisis and the critical role that education and awareness play in combating addiction. By understanding the unethical practices that have fueled this epidemic, we can better support those struggling with addiction and advocate for meaningful change.
This episode isn't just about recounting a court case; it's a call to action. It emphasizes the importance of holding both pharmaceutical companies and healthcare providers accountable. Tune in to hear how this landmark sentencing could pave the way for a more transparent and responsible approach to opioid prescriptions.